MedPath

KONKUK UNIVERSITY MEDICAL CENTER

KONKUK UNIVERSITY MEDICAL CENTER logo
🇰🇷South Korea
Ownership
Private
Established
1931-01-01
Employees
101
Market Cap
-
Website
http://www.ihc.kuh.ac.kr

Clinical Trials

197

Active:13
Completed:96

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:1
Phase 2:3
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (168 trials with phase data)• Click on a phase to view related trials

Not Applicable
139 (82.7%)
Phase 4
23 (13.7%)
Phase 2
3 (1.8%)
Early Phase 1
1 (0.6%)
Phase 1
1 (0.6%)
Phase 3
1 (0.6%)

Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery

Not Applicable
Not yet recruiting
Conditions
Mitral Regurgitation
Mitral Stenosis
Tricuspid Regurgitation
Interventions
Procedure: Acute normovolemic hemodilution (ANH)
Drug: hydroxyethyl starch (HES 130/0.6)
First Posted Date
2024-10-29
Last Posted Date
2024-10-31
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
70
Registration Number
NCT06664320
Locations
🇰🇷

Konkuk University Medical Center, Seoul, Korea, Republic of

Comparison of Time Taken to Diagnose Intraoperative Coagulopathies Using VET and SCL

Not yet recruiting
Conditions
Arthritis of Knee
Arthritis of Hip
Spine
Prostate Cancer
Hepatic Cancer
Valvular Disorder
Ischemic Heart Disease
Aortic Diseases
First Posted Date
2024-10-11
Last Posted Date
2024-10-11
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
210
Registration Number
NCT06637943

Effect of MTX Discontinuation on Shingrix Response in RA

Not Applicable
Recruiting
Conditions
Rheumatoid Arthritis
Interventions
First Posted Date
2024-08-28
Last Posted Date
2024-08-28
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
110
Registration Number
NCT06574594
Locations
🇰🇷

Konkuk University Medical Center, Seoul, Korea, Republic of

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Cardiac Surgery

Phase 4
Not yet recruiting
Conditions
Cardiac Valve Disease
First Posted Date
2023-11-22
Last Posted Date
2023-11-22
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
152
Registration Number
NCT06144125

Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery

Phase 4
Not yet recruiting
Conditions
Prostate Cancer
Spine, Open
Hip Osteoarthritis
Knee Disease
First Posted Date
2023-11-22
Last Posted Date
2024-01-02
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
154
Registration Number
NCT06144099
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

News

Huonslab Completes Enrollment in Phase 1 Trial for Recombinant Hyaluronidase, Eyes 2025 Regulatory Filing

Huonslab has completed patient enrollment in its pivotal Phase 1 clinical trial of HLB3-002 (Hydizyme™), a recombinant human hyaluronidase, with 243 healthy volunteers across four leading South Korean medical centers.

Leclaza Downstages Lung Cancer in 55% of Patients in Preoperative Trial

A Korean study found that nine weeks of Leclaza treatment can lower the stage of inoperable lung cancer patients with EGFR mutations, making them eligible for surgery.

ROTEM-Guided TXA Administration vs. Preemptive TXA for Bleeding in Cardiovascular Surgery: A Randomized Trial

A multi-center, double-blind, randomized trial is underway to compare ROTEM-guided tranexamic acid (TXA) administration with preemptive TXA in cardiovascular surgery patients.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.